Cargando…
Proteomics Suggests a Role for APC-Survivin in Response to Somatostatin Analog Treatment of Neuroendocrine Tumors
CONTEXT: Somatostatin analogs are established in the treatment of neuroendocrine tumors (NETs) including small intestinal NET; however, the molecular mechanisms are not well known. Here, we examined the direct effects of lanreotide in NET cell line models. SETTING AND DESIGN: The cell lines HC45 and...
Autores principales: | Fotouhi, Omid, Kjellin, Hanna, Larsson, Catharina, Hashemi, Jamileh, Barriuso, Jorge, Juhlin, C. Christofer, Lu, Ming, Höög, Anders, Pastrián, Laura G., Lamarca, Angela, Soto, Victoria Heredia, Zedenius, Jan, Mendiola, Marta, Lehtiö, Janne, Kjellman, Magnus |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Endocrine Society
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5052342/ https://www.ncbi.nlm.nih.gov/pubmed/27459532 http://dx.doi.org/10.1210/jc.2016-2028 |
Ejemplares similares
-
Copy number alterations in small intestinal neuroendocrine tumors determined by array comparative genomic hybridization
por: Hashemi, Jamileh, et al.
Publicado: (2013) -
Genetic and epigenetic background and protein expression profiles in relation to telomerase activation in medullary thyroid carcinoma
por: Wang, Na, et al.
Publicado: (2016) -
Global hypomethylation and promoter methylation in small intestinal neuroendocrine tumors: An in vivo and in vitro study
por: Fotouhi, Omid, et al.
Publicado: (2014) -
Differential Protein Expression Profiles of Cyst Fluid from Papillary Thyroid Carcinoma and Benign Thyroid Lesions
por: Dinets, Andrii, et al.
Publicado: (2015) -
Frequent Promoter Hypermethylation of the APC and RASSF1A Tumour Suppressors in Parathyroid Tumours
por: Juhlin, C. Christofer, et al.
Publicado: (2010)